Spinal Cord Stimulation Devices Market in Europe is expected to register a CAGR of 7.6% during the forecast period (2019-2025) - KBV Research

16-Oct-2019 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Europe Spinal Cord Stimulation Devices Market, published by KBV Research, the Europe Spinal Cord Stimulation Devices Market would witness market growth of 7.6% CAGR during the forecast period (2019-2025).

The Germany is one of the major revenue generating regions within the Europe Rechargeable Market by Country in 2018. The Germany witnesses a growth rate of 6.45% within this market space during the forecast period. The France market is expected to witness a CAGR of 8.6% during (2019 - 2025). Additionally, The Spain market is expected to witness a CAGR of 8.05% during (2019 - 2025).

The Coating market witnessed a share of more than 25% of the Russia Spinal Cord Stimulation Devices Market by Application in 2018. The Unsuccessful Disk Surgery witnesses a significant growth during the forecast period and grows at a CAGR of 8.55% during (2019 - 2025). The Degenerative Disk Disease segment would grow with the highest CAGR during the forecast period.

The Rechargeable market dominated the Russia UV Curable Resin Market by Resin Type in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $113.8 Million by 2025, growing at a CAGR of 6.2 % during the forecast period. The Non-Rechargeable market would grow with a significant CAGR of 8.1% during (2019 - 2025).

Full Report:https://www.kbvresearch.com/europe-spinal-cord-stimulation-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.